Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 75 citing articles:

The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
Stefano Toldo, Antonio Abbate
Nature Reviews Cardiology (2023) Vol. 21, Iss. 4, pp. 219-237
Closed Access | Times Cited: 110
NLRP inflammasomes in health and disease
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 20
The role of NLRP3 inflammasome in aging and age-related diseases
Ruikai Liang, Xinrui Qi, Qi Cai, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Chlorogenic acid inhibits NLRP3 inflammasome activation through Nrf2 activation in diabetic nephropathy
Liping Bao, Yuhan Gong, Wenfang Xu, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316615-e0316615
Open Access | Times Cited: 1
Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects
Pasquale Pagliaro, Cláudia Penna
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1396-1396
Open Access | Times Cited: 24
Ursolic Acid Alleviates Neuroinflammation after Intracerebral Hemorrhage by Mediating Microglial Pyroptosis via the NF-κB/NLRP3/GSDMD Pathway
Pan Lei, Zhiyang Li, Qiuwei Hua, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14771-14771
Open Access | Times Cited: 24
Acacetin inhibits inflammation by blocking MAPK/NF-κB pathways and NLRP3 inflammasome activation
Juan Bu, Yeledan Mahan, Shengnan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice
Jingjing Shao, Weifeng Li, Jinfeng Sun, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 4, pp. 803-814
Closed Access | Times Cited: 11
Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors
Ye Tao, Weiyan Tao, Xiaoyi Chen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 1-13
Closed Access | Times Cited: 16
Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023
Meibo Duan, Lei Sun, Xinzi He, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115750-115750
Closed Access | Times Cited: 15
Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons
Juan Yu, Zhanghong Zhao, Yuanyuan Li, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28838-e28838
Open Access | Times Cited: 6
The Role of Inflammasome in Abdominal Aortic Aneurysm and Its Potential Drugs
Suyu Pi, Sizheng Xiong, Yan Yuan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5001-5001
Open Access | Times Cited: 6
Recent advances in the effect of adipose tissue inflammation on insulin resistance
Kaiyi Yan
Cellular Signalling (2024) Vol. 120, pp. 111229-111229
Closed Access | Times Cited: 5
Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers
Lu Yang, Jiamin Gao, Yachen Hou, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010127-e010127
Open Access
The research trends and hotspots of NLRP3 inflammasome in Alzheimer's disease: a bibliometric and visualization analysis
Xuanwei Wen, Huiye Yang, Shuangxi Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Anemoside B4 targets NEK7 to inhibit NLRP3 inflammasome activation and alleviate MSU-induced acute gouty arthritis by modulating the NF-κB signaling pathway
Xinghua Ni, Qinqin Wang, Yujie Ning, et al.
Phytomedicine (2025) Vol. 138, pp. 156407-156407
Closed Access
Nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing protein 3 inflammasome: From action mechanism to therapeutic target in clinical trials
Chunye Zhang, Shuai Liu, Yuxiang Sui, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
Tetrahedral Framework Nucleic Acid (tFNA)‐Loaded Metformin (Met) Modulates Cellular Pyroptosis and AMPK to Ameliorate Type II Diabetic Periodontitis
Qi Han, Jiaqi Li, Hao Deng, et al.
Small (2025)
Closed Access
Degrading the key component of the inflammasome: Development of an NLRP3 PROTAC
Tim Keuler, Dominic Ferber, Jonas Engelhardt, et al.
Chemical Communications (2025)
Closed Access
Five Key Criteria for Identifying Optimal Therapeutic Targets in Protein‐Mediated Diseases
Mohammed Baqur S. Al‐Shuhaib, Jafar M. B. Al‐Shuhaib
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access
Macrophage-targeting nano-formulated bicalutamide alleviates colitis by inducing MAP3K1-mediated degradation of NLRP3
Suqin Zhong, Suzhen Zhong, Yi Wu, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 417-432
Closed Access
Ligusticum cycloprolactam ameliorates hyperuricemic nephropathy through inhibition of TLR4/NF-κB signaling
Zhe Chen, Rong Chen, Jiamin Wang, et al.
The Journal of Nutritional Biochemistry (2025), pp. 109864-109864
Open Access
Nrf2/Nlrp3 Signaling in Aging Bmscs: Traf6 Intervention as a Novel Approach to Osteoporosis Treatment
Yajun Li, Yunshang Yang, Ding Xia, et al.
(2025)
Closed Access
Exploring Global Natural Product Databases for NLRP3 Inhibition: Unveiling novel combinatorial therapeutic strategy for Hidradenitis Suppurativa
Muhammad Suleman, Abduh Murshed, Abrar Mohammad Sayaf, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 4, pp. 102697-102697
Open Access
Ubiquitin‐specific protease 25 improves myocardial ischemia–reperfusion injury by deubiquitinating NLRP3 and negatively regulating NLRP3 inflammasome activity in cardiomyocytes
Bozhi Ye, Diyun Xu, Lingfeng Zhong, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top